To obtain access to any datasets listed on this site, you must first receive approval from NIDA Datashare's Data Access Committee (DAC).

Please submit your request by sending your request to NIDA_Datashare_DAC@mail.nih.gov along with the following information:

  • Your name, title, and organization
  • Study Number and Study Title
  • The specific dataset(s) you are requesting
  • The intended use or purpose of the data
  • Willingness to comply with the NIDA Datashare Registration Agreement
Once your request is reviewed, you will receive instructions on how to proceed.

Thank you for your cooperation.

NIDA-CPU-0008

Division
DTMC
HEAL Study
No
Investigator(s)
Reese Jones, M.D.
Title
Double-Blind, Placebo-Controlled Assessment of Interactions Between Intravenous Methamphetamine and Modafinil
Short Description
Study to assess the potential interactions between intravenous methamphetamine and oral Modafinil
Release Date
Dec 21, 2017
Description

The primary aims of this study are to determine if there are significant safety interactions between oral modafinil and intravenous methamphetamine. Safety will be assessed by measuring adverse events and cardiovascular responses of heart rate (HR), blood pressure (BP), and electrocardiogram (ECG) and stroke distance (ICG).

Keywords
methamphetamine
modafinil
interaction
phase 1a
stimulant
Assessments
Brief Substance Craving Scale
ECG Monitoring
Profile of Mood States
Visual Analog Scales
Vital Signs Monitoring
Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Links
ClinicalTrials.gov Link
CPU-0008 in NIH clinical trials registry